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REPORT OF THE SCIENTIFIC COMMITTEE FOR FOOD ON THE SrNSITO/ITY 
OF INDIVIDUALS TO FOOD COMPONENTS AND FOOD ADDITIVES 
(Opinion expressed 22 October I98I) 
TERMS OF REFERENCE 
To complete the review of the topic of hypersensitivity and intolerance to food additives 
and to advise on the relevance of this subject to public health. 
BACKGROUND 
It has been well established for a number of years that various "allergic" reactions may be 
caused in sensitized individuals following the ingestion of food additivee. Since the 
initial observations of these effects there has been an increasing number of scientific 
publications on the eubject. The Committee has drawn the attention of the Commission to 
this problem particularly in its report on Certain colouring matters for use in food 
(opinion expressed 23 March 1979) · Indeed opposition has been expressed within the Committee 
to the addition to food of any colour alleged to cause allergic reactions, although this has 
been countered by the argument that where the incidence of allergic reactions is low, 
acceptability might be considered. In 1979 "the Committee recommended to the Commission 
that it should convene experts in this specialised field to advise on the lateet scientific 
information relating to such adverse reactions due to ingested food additives and drew 
attention to the parallel problems that might arise in the case of pharmaceuticals, and, in 
some cases, cosmetics. The present opinion is adopted in the knowledge of the conclusions 
of the working group set up by the Commission. 
DISCUSSION 
It should be stressed that in the present opinion the Committee has restricted its comments 
to food components and food additives but it is the total exposure from food, pharmaceuticals 
and cosmetics that pose the potential problem. The Committee reiterates its recommendation 
that competent bodies in these fields- should be reminded of this fact. 
The Committee was impressed by the information presented in the report of the Commission's 
working group on adverse reactions to ingested additives and concluded that this report 
should be annexed to the preeent report because it surveyed comprehensively the most recent 
scientific and medical information available. The Committee does not intend to repeat the 
detailed findings in its own report. It also approves the tenor of the recommendations in 
the report, but believes that more precise recommendations should be formulated by the 
Scientific Committee for Food in respect of food ingredients and particularly food additives. 
In recent time much of the debate about sensitivity of individuals to food components and 
ingredients has concentrated on adverse reactions arieing from the ingestion of food additives. 
Individuals learn by experience which foods are likely to cause disagreeable effects, but 
the susceptible subject is less easily able to identify the causative agent for the adverse 
reaction experienced if this is a food additive in a manufactured food. 
The Committee is aware that the Council Directive on the approximation of the laws of the 
Member States relating to the labelling, presentation and advertising of foodstuffs for sale 
to the ultimate consumer2 prescribes a complete list of ingredients for foods. The 
Committee endorses this principle but notes that for specific individuals sensitive to 
particular food components some of the relevant information might be lacking. These 
problems might well be resolved by Directives applying to specific foodstuffs principles 
of the Council Directive on the approximation of the laws of the Member States relating to 
foodstuffs for particular nutritional uses3. 
the term "allergy" is used to denote both true allergy (or hypersensitivity) and intolerance 
(or idiosyncracy) 
Reports of the Scientific Committee for Food, 8th Series, I979 
20J L 33 of 8.2.1979, P. 1 
30J L 26 of 3l.l.l977i P. 55 The Labelling Directive includes food additives in the definition of ingredient and thue 
these too must te indicated. In most cases this indication must be by the name of the 
category to which the additive belongs followed by a specific indication of the individual 
additive. The Committee has recommended in the past that there should always be clear and 
appropriate labelling of food additives so that the consumer can be aware of the contents 
of the food. It is especially important, with relation to individuals sensitized by food 
additives, that the wording is not only visible and understandable to the lay person but 
also meaningful to the medical practitioner. 
The advantage of the "EEC No." is its simplicity, but many members of the Committee felt that 
the consumer in general was not aware of what this system entailed and that the medical 
profession in particular was not conversant with the details of the lists. The Committee 
stresses the importance of finding some way of informing consumers and their doctors in 
an objective manner on what the "EEC numbering system" involves. 
The evidence presented to the Committee clearly demonstrates that in many cases of adverse 
reactions to food a dose/effect relationshop exists. It is evident therefore that a 
reduction in the total ingestion of the particular additive by the person likely to be affected 
by the additive would be "beneficial. Reduction of intake can, in general terms, be brought 
about either by limiting the categories of food permitted to contain the additive or by 
lowering the amount of the additive in a particular foodstuff. 
It seems to the Committee that for some additives the use level is in excess of that 
necessary to achieve the desired effect and the Committee supports the working group in 
its recommendation that a more rigorous appraisal of technological need should be undertaken 
in defence of the health of individuals sensitized by food additives. This problem is not 
only relevant to "allergy" and has been discussed in detail in the Committee's Guidelines 
for the Safety Assessment of Pood Additives4. 
However, the Committee is not advocating a general lowering of present levels of additives 
unless a fundamental appreciation of the effects is understood. In this context the 
Committee has some grounds for believing that the use of additives whose role appears 
mainly to be organoleptic (e.g. colouring matters) is too widespread and there are good 
grounds for reducing their ingestion to the absolute minimum necessary. This is particularly 
relevant for substances causing the adverse reactions of the type presently under discussion 
Where the effects noted are particularly severe or where the effects are widespread in the 
population, the Committee is of the opinion that a total ban on the substance in question 
should be envisaged as the ultimate reduction in use. 
Each food additive represents a special problem as the socio-economic factors surrounding 
its use have to be taken into account by the legislative authorities in deciding on the 
appropriate measures to be taken. For this reason the Committee has taken a deliberate 
decision to limit its advice to questions of principle. 
Por practical reasons the Committee decided that it had to make a distinction between 
additives of long usage and additives to be introduced in the future. 
Althou^i the very nature of the problem and the limitations of the available testing 
techniques make it difficult to perform a complete assessment of potential allergenicity 
of chemicals, the Committee believes that all existing food additives suspected of provoking 
adverse reactions should be tested for allergenicity. Moreover the Committee considers that 
it would be reasonable to suggest to manufacturers that where there are grounds for 
suspicion — without scientific proof — that an additive already permitted in food is 
causing severe or widespread effects, manufacturers and users have a responsibility to 
provide proof that the suspicion is invalid, or to phase out or at least significantly reduce 
the uses of such an additive. 
Por new food additives a more strict attitude is to be envisaged. Test systems to detect 
"allergenicity" should be included routinely in toxicity assessments of new food additives. 
^Reports of the Scientific Committee for Pood, 10th Series, I98O, EUR 6892 At present the existing methods should be applied, even though the results of these tests 
are in some cases not sufficiently predictive. 
The Committee considers it essential that new methods are devised and developed to assess 
the reactions of hypersensitivity and intolerance that might te provoked by such additives 
so that a meaningful evaluation of their acceptability is more easily made. Moreover the 
Committee endorses the conclusion of the working group that there is an immediate and 
fundamental need for research to be carried out on the epidemiology of, and basic mechanisme 
concerned, in adverse reactions to food additives. 
As has often been stated, in any toxicological evaluation the material tested should conform 
to an adequate specification. In the case of "allergy" particular attention should be given 
to the possible effects of specific impurities present in the additive and to metabolites 
associated with it since their presence could be the factor determining the adverse effect. 
SUMMARY OF CONCLUSIONS 
1. The Committee endorses the conclusions of the Commission's working group on adverse 
reactions to ingested additives. 
2. The presence of additives in food should be mentioned by a speoific indication for each 
additive which is informative to the consumer and the medical practitioner. 
3. A more rigorous appraisal should be undertaken on the technological need for food 
additives with a view to a reduction in the total ingestion either by lowering permitted 
levels or by limiting the numbers of foodstuffs in which they are permitted. 
4. In respect of food additives to be introduced and additives already in use suspected of 
having an effect on sensitized individuals, tests systems to detect "allergenicity" should 
be included in toxicity assessments. 
5. New methods should be developed to assess adverse reactions of hupersensitivity and 
intolerance. 
6. There is an immediate and fundamental need for research into the epidemiology and basic 
mechanisms concerned in adverse reactions to food additivee. ANNEX 
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1. INTRODUCTION 
Allergio reactions to certain foods are a long recognised problem. Often an individual 
will 'feel' that a particular food does not agree with him and will avoid eating that 
food (e.g. egga, milk, shellfish or strawberries). The increasing replacement of fresh 
foods by manufactures 'convenience' foods has been accompanied by the use of food additives 
(e.g. preservatives, antioxidants and colouring agents). The realisation that similar 
adverse reactions can also be caused by such additives, in susceptible subjects, has 
resulted in questioning their continued use. Prompted by the preoccupations of its 
scientific advisers in the food, pharmaceutical and cosmetic sectors the Commission 
decided to set up this working group to review and report on hypersensitivity. Adverse 
reactions to food additives also involves drugs and cosmetics, since most components used 
in the formulation of drugs and several used in cosmetics are selected because of their 
toxicological clearance for safety-in-use as food additives. Discussion in this paper 
will deal mainly with adverse reactions from ingestion of food additives, in the hope 
that it will be possible to derive a common policy applicable to all food additives, 
but much that is said will be applicable to pharmaceutical products and cosmetics. The 
term allergy is often used for any adverse reaction resulting from ingestion of a 
particular food or additive. However it hae been established that, despite their clinical 
similarity, such reactions are of two different types — true allergy (or hypersensitivity) 
which results from an immunological mechanism, and intolerance (or idiosyncracy) when no 
immunological basis is apparent. Our understanding of these mechanisms is incomplete and 
limited by a lack of appropriate laboratory teets. Nevertheless, it seems that most 
adverse reactions to food additives are manifestations of intolerance rather than allergy 
Therefore we have used this more specific terminology whenever possible. But these 
adverse reactions to food are still likely to be considered as "allergy" in any general 
discussion of the problem. 
Definitions of the terms used in this report are attached in Annex I. 
2. CLINCIAL PICTURE 
When the additive gains aocess into the body of a susceptible subject, irrespective of 
whether it triggere off an immunological or other mechanism, it produces clinical 
manifestations which cause a very variable degree of discomfort. The most common 
manifestations of intolerance or hypersensitivity occur in the respiratory tract, skin a 
and gut, but other systems such as the nervous and vascular systems may be affected. 
In any individual the target organ pattern is likely to be rather constant. 
Skin 
It is probable that hypersensitivity or intolerance to food additives can be manifested 
in the skin in a variety of ways. Rashes which should be considered as possible skin 
manifestations of such reactions include eczema, purpura, erythema multiforme and fixed 
drug eruption. A relationship between quinine ingestion and purpura has been documented 
in occasional patients (e.g. Belkin, 1967; see also review by Baylon, 1979)· A case of 
recurring purpura due to tartrazine (Criep, 1971)· tartrazine and benzoatos (Kubba and 
Champion, 1975)· ejià seven patients with purpura following ingestion of azo—dyes and 
benzoatos (Hichaelsson et al, 1974)· have also been reported. In the outbreak of 'Dutch 
margarine disease' in the late 1930s the erythema multiforme—like eruption which 
developed in patients consuming a particular brand of margarine was attributed to the use 
of a novel emulsifier (Mali and Malten, I96I). 
Contact dermatitis due to additives in food and drugs has been described but is rare 
(Fischer, 1973). It is more common from additives used in topical medications and 
cosmetics (Wilkinson, 1972). But it is possible, and in some instances demonstrable, that 
ingestion of the sensitiser (or a related cross—reacting compound) may produce a flare—up 
in the contact dermatitis. Such a situation may occur with azo—dyes, antioxidants 
(e.g. BHA and BHT), preservatives (e.g. parabens, sorbic acid), flavourings (e.g. 
cinnamon, quinine) or stabilisers (e.g. ethylene diamine hydrochloride) where the 
sensitising additive is used in pharmaceutical preparations and/or cosmetics as well as 
in food. 
The only well defined, common dermatoses in which present evidence suggests food 
additives play a significant part are chronio urtioaria and angio-oedema. - 8 
Urticaria is a common symptom, likely to affect one in five persons at some time. The 
weals are due to histamine release, which in acute urticaria is often the result of an 
allergic reaction to a drug or food. In recurrent or chronic urticaria, the situation is 
more complicated. Certain foods and drinks are mentioned by 4C$ of patients as possible 
agents which worsen or provoke their urticaria (Juhlin, I98I). Several studies, 
testing for such hypersensitivity "by provocation tests, have now heen published. An 
urticarial reaction to an azo—dye, tartrazine, was first reported by Lockey (1959). 
Samter and Beers (1968) found that some of their aspirin-sensitive patients with urticaria 
also reacted to tartrazine. Juhlin et al (1972) found this true for 7 out of 10 patients 
with aspirin intolerance. Some also reacted to 'benzoic acid and its derivatives. Half 
of 52 patients with chronic urticaria reacted, with urticaria, to different azo-dyes and 
henzoic acid compounds (Michaelsson and Juhlin, 1973). The doses used for provocation 
tests can be exceeded by normal daily consumption of food and drugs. Investigation of 
330 patients with chronio urticaria from I974-I979 (Juhlin, I98I), with various coded 
food additives and placebo, showed at least 31$ with positive provocation tests. 
Azo-dyes (l8$), benzoates (11$), aspirin (22$), annatto (10$), BHA, BHT (15$), quinoline 
yellow (13$) and yeast (16$) formed the bulk of the positive reactions. A breakdown of 
positive reactions obtained in a similar group of patients by Mikkelson et al (I978) 
showed the following percentage proportions: 26$ for annatto, 11$ for tartrazine, 
17$ for Sunset Yellow, 16$ for Pood Red. 17, 9$ for Amaranth, 15$ for Ponceau 4R, 12$ for 
erythrosine and 14$ for Brilliant Blue. There are many other reports of reaction to food 
colours in patients with ohronic urticaria. It should be noted that although most 
attention has been paid to tartrazine these studies show that it is not only tartrazine 
that causes skin reactions. Patients with chronic urticaria have been shown to improve 
on a diet free from azo-dyes and preservatives (Thune and Granholt, 1975; Ros et al, 
1976; Warin and Smith, I9765 Douglas, 1977; Preedman, 1977; Rudzki, 1977; August, 1979). 
Respiratory tract - asthma, rhinitis and nasal polyps are the main symptoms. Aspirin 
has been known to cause serious reactions in some patients with asthma since I9I9 (Cooke). 
Patients may have rhinitis and nasal polyps preceding the bronohoconstrictor type of 
(asthmatio) intolerance to aspirin by months or years. Aspirin sensitive patients often 
show intolerance to other analgesics (Smith, I97I). Speer (1958) reported that colouring 
matters can precipitate an asthmatic attack. Cross reaction to tartrazine in about 8 to 
15$ of aspirin-Bensitive asthmatic patients has been reported by several authors (e.g. 
Settipane et al, I967 and 1975). Similar cross reactions with various benzoates have 
also been found (e.g. Juhlin et al, 1972). Rosenhall (1977) tested 504 patients, with 
asthma and rhinitis, for hypersensitivity to food colouring matters, preservatives and 
analgesics. Reaotion to at least one of the substances occurred in IO6 patients. In 33 
patients reacting to tartrazine, 42$ showed intolerance to aspirin and 39$ to sodium 
benzoate. Although dietary treatment was found to be effective in some patients, in 
preventing exacerbation of the disease, on the whole it did not influence the course of 
the disease, or the need for medication. Stenius and Lemola (1976) tested I40 asthmatics 
for reaction to aspirin and tartrazine. Most of the patiente who reacted to tartrazine 
also reacted to aspirin, and about one third of them were able to give a history of 
reaction to colouring matters in food and drinks. While investigating patients with 
asthma who experienced attackes shortly after ingestion of orange soft drinks, and agreed 
to undergo challenge tests, Preedman (1977b) found that of a total of I4 patients, 8 
gave positive tests to eulphur dioxide, 4 to sodium benzoate and 1 to tartrazine. This 
is the first report of asthma following ingestion of a beverage containing sulphur dioxide. 
Investigation of children with asthma suggests that hypersensitivity or intolerance to 
food additives may be less common. Speer (1958) described reactions to tartrazine in 
children, but Vedanthan et al (1977) found no such adverse response after tartrazine 
provocation in 56 asthmatic children. Østerballe et al (1979) found that only 3 out of 
46 asthmatic children had positive reactions to aspirin, benzoates or dyes. Similar 
results were obtained by Weber (1979) among 45 children. Only Syvanen and Backman (1978) 
have reported a situation similar to that obtained in adult asthmatics: of 32 children, 
33$ showed intolerance to aspirin, 18$ to sodium benzoate and 20$ to tartrazine. 
Other clinical manifestations 
Although there is definite evidence that allergic or idiosyncratic reactions involving 
the skin and respiratory tract can result from ingestion of food additives, this is not 
the case for adverse reactions involving other systems, such as the digestive or nervous 
system. It must be emphasised that in most of the following clinical situations there 
is little data to support the diagnosis of adverse reactions to food, and even less 
evidence that the symptoms are the result of hypersensitivity or intolerance to food 
additives. - 9 -
a) Anaphylaxis is a very serious form of immediate immune reaction in which a state of 
generalised Bhock occurs and the outcome can be fatal. Anaphylactic reactions do not 
often result from food ingestion. They are known to have occurred after eating fish, 
eggs and celery for example; and very exceptionally have been attributed to particular 
food additives (Lockey, 1971). 
b) Gastro-intestinal tract 
The consideration that adverse reactions may easily affect the site of entrance of the 
food or additive, suggests that the gastro-intestinal tract may be a major target in 
hypersensitivity or intolerance to food and food additives. Nausea, vomiting, 
diarrhoea, abdominal distension, pain and bleeding are the commonest symptoms ascribed 
to such adverse reactions to food. These symptoms may occur alone or in association 
with respiratory and/or skin disturbances. When only gastro-intestinal symptoms occur, 
the diagnosis of an adverse reaction to food may not be at all obvious, since identical 
symptoms may result from chemical or microbiological contamination of food, or some 
psychological problem — furthermore mild gastro—intestinal upsets are part of everyone's 
experience and often ignored. ■ There is therefore virtually no information about the 
inoidenee of uncomplicated gastro-intestinal manifestations of food allergy or 
intolerance assooiated with additives. 
c) Nervous system 
"Allergy" has long been reported to be a cause of headache and migraine. Out of 100 
patients suffering from "allergic" headache, food was found to provide a relevant 
allergen in 87 (Rowe and Rowe, 1972). In patients with chronic migraine (2 to 3 
attacks a week), diets avoiding the most common allergens may be effective in 85$ of 
cases (Grant, 1979) - and use of the RAST, to detect specific antibodies has been 
suggested as a guide to appropriate dietary exclusion (Monro et al, I98O). But 
additives have not been specifically implicated. 
Hyperkinesia 
Purposeless overactivity with concentrating and learning difficulties may be present in 
from 0.09$ (Rutter et al, I969), to 1.19 to jfo of young children (Lambert, et al, 1978). 
Both non—scientific and scientific speculation on this condition stems from Feingold's 
suggestion in 1973 that dyes, preservatives and other additives could be responsible. 
His claim that a diet free from artificial food colouring matters and flavourings 
produced a dramatic and rapid improvement in 25 to 50$ of hyperactive children, hae 
not been substantiated in double—blind trials with food colouring matters. Flavourings 
have not been similarly tested. The evidence is well reviewed by Lipton (1979)· Even 
BtudieB in hyperactive children using bolus doses from 26 to I50 mg of colouring 
matters lend no support for Feingold's hypothesis, although it was apparently possible 
to demonstrate impairment of visual tracking performance (Conners et al, 1976) and 
concentrating ability (Swanson and Kinsbourne, I98O). 
Various other neurological syndromes and symptoms have been reported due to food 
"allergy" (e.g. "allergic" tension—fatigue syndrome} mood and behavioural disturbances, 
transient paresis and paraesthesiae, vision and speech abnormalities, etc.). There 
is little evidence to Bupport these suggestions. Weiss et al (198O) reported that out 
of 22 children with behavioural problems (other than hyperkinesia) who had previously 
shown improvement on an elimination diet, one child aged just under 3 years old was 
assessed by its mother to have responded positively to challenge with a blend of 
7 artificial colouring matters. 
It would therefore be fair to Btate that there is no good evidence to support Feingold's 
hypothesis; but it is perhaps not possible to give all food additives a completely 
clean bill in terms of behavioural toxicity. (See Report of the National Advisory 
Committee on hyperkinesia and food additives, I980) 
d) Urogenital allergy 
Since the original report of Duke in 1922, the possibility that bladder urgency, 
frequency and strangury may be caused by "allergy" to food and additives has been 
repeatedly reported (Horesh, 1976; Dickey, 1977). The oedema and spasm of the 
bladder resulting from allergic reactions have been claimed to be responsible for 
incomplete emptying with subsequent recurrent infections and enuresis (Gerrard and 
Zaleski, 1977)· 10 
The presence of IgE in glomeruli of some patients with nephrotic syndrome (Paronetto 
and Gerber, 1971) has interested those who believe that dietary allergies may be of 
importance to urogenital pathology. 
e) Articular and muscular allergy 
"Allergy" to food and food additives as a cause of arthritis and arthralgias, as well 
as of muscular pain and fatigue, is often reported. Varying degrees of improvement 
with elimination diets have been described in patients with intermittent hydrarthrosis, 
palindromic rheumatism and even rheumatoid arthritis (see Rowe and Rowe, 1972)· 
Recently, hypersensitivity to tartrazine as shown by positive RAST on synovial fluid, 
and by positive challenge with the dye, has been demonstrated in a patient with asthma 
and pain and swelling in the knee joints. Symptoms were completely relieved by 
avoidance of tartrazine in the diet, drinks and chewing gum (Wraith, I98O). 
f) Ocular allergy 
Contact dermatitis of the eyelids resulting from additives, as well as oedema of the 
eyelids, conjuctivitis and corneal pathology caused by food allergy have been 
reviewed by Rowe and Rowe (1972). 
g) Ear allergy 
Pood allergy has been invoked as the cause of such conditions as chronic exudative 
serous otitis externa, Meniere's syndrome, and impaired hearing due to oedematous 
blockage of the Eustachian tubes. 
FREQUENCY OP AWERSE REACTIONS TO FOOD ADDITIVES 
It is obvious from the previous sections that it is difficult to assess the number of 
cases of food allergy and intolerance since diagnosis is largely dependent on the 
subjective methods of history taking, elimination diets and challenge studies. A 
minimum of 0.2$ for food allergy is suggested in a recent Danish Report (Poulsen I98O). 
Moneret-Vautrin and Grilliat (1979) suggest that if 15$ of the population have allergic 
problems 6$ will be cutaneous, 5$ ENT, 3$ bronchial and only 0.5 to 1.0$ digestive in 
origin. This last figure agrees with Smiths estimations (1974) of less than 1$. When 
it comes to trying to assess the frequency of allergy, or intolerance, to certain food 
additives the problem is even greater; yet those who have to regulate the use of these 
additives need to know the size of the problem. Moat of the good studies have been 
carried out in selected populations; and more information is available on the colouring 
matters in general and tartrazine in particular than for other food additives. The 
frequency of tartrazine sensitivity amongst the allergic population, as determined by 
skin or challenge tests, is very variable. Juhlin has reviwed the literature for 
information and used this with his own data to calculate the frequency of adverse 
reactions to some of the food additives. But he points out that when the diagnosis of 
intolerance or hypersensitivity depends upon provocation tests, then the recorded 
frequency is bound to vary with selection of patients, and dosage, and on the 
observation times used in the tests. 
Food additives induced urticaria or angio oedema in about one third to half the patients 
with chronic urticaria. From this it was calculated that in a population of 10 million, 
additives will cause urticaria each day in 2,200 people, and that each year about the 
same number of patients will be referred to a specialist because of their sensitivity to 
additives. Of the individual additives, tartrazine is the most commonly tested azo-dye 
— it gave positive reactions in from 5 "to 46$ of patients. Other azo—dyes gave from 
5 to 20$ positives, and the natural colouring matters, aimatto, from 8 to 26$. Amongst 
preservatives, benzoates are the most frequently teeted, and gave positive reactions in 
from 3 to 44$» sorbió acid positive reactions were found in 6$ of patients, and the 
antioxidants BHA and BHT gave from 14-15$ positive results. 
When considering asthma the facts can be summarised:— The prevalence of asthma in adult 
and childhood populations is very similar (2-6$ and 0.5-10$ respectively). Intolerance 
to aspirin is well recognised amonst asthmatics — the frequency increases with increasing 
age. About 8—10$ of patients show intolerance; unless severe asthmatics are treated 
separately, when 16—18$ are intolerant. Some 8—44$ of aspirin intolerant asthmatics 11 -
show oroΒs—reactivity with tartrazine, and 14$ with variouB benzoatos. Amongst 32 
children with asthma, aspirin intolerance was found in 33$, and sensitivity to sodium 
benzoato in 18$ and tartrazine in 20$ (Syvanen and Backman, 1978)· These figures have 
to he compared with a zero incidence of adverse reactions to tartrazine found by Vedanthan 
et al (1977)1 and those of Østerballe et al (l979) whose initial testing suggested that 
24$ of children with asthma showed intolerance to aspirin, benzoates or dyes, but on 
double-blind retesting with placebo found only 6.3$. Prom this background information 
it was roughly calculated that in every 10 million people, about 40,000 will have 
intolerance to aspirin (0.4$), 6,000 to tartrazine (0.06$) and 5,000 to benzoates (0.09$). 
Estimates of the incidence of tartrazine sensitivity in the whole French population have 
been made by Pellegrin (1979): 0.19$; and Moneret-Vautrin et al (l98o)t 0.03$. 
In the Danish study reported by Poulsen (198O) a more systematic approach was used in 
an attempt to assess the frequency of reactions to food additives. 
First the frequency (one year prevalence) in the general adult population, of asthma, all 
year rhinitis and chronio urticaria was determined as being 3.8$, 1.9$ and 0.5$ 
respectively. Subsequently the frequency of adverse reactions to food additives in these 
selected population groups was established by reference to previous provocation tests 
with food colouring matters and benzoates, on the basis of cross reactivity with aspirin. 
From these investigations, the frequency of intolerance to food additives in the Danish 
population (aged above 16 years) was calculated to be of the order of 1,000 per million 
(0.1$) for both tartrazine and benzoates. These frequencies were considered high by 
Danish allergy specialiste (and an explanation was offered in the facts that there was 
a high frequency of chronic urticaria, and that the doses of colourings matters, other 
than tartrazine, used in the provocation tests were above expected levels of daily 
intake). But they agree with a combination of Juhlin's figures, calculated from food 
additive sensitivity in chronic urticaria, and tartrazine and benzoate sensitivity in 
asthma. Therefore when attempting to quantify the problem of adverse reactions to 
food additives, it is only possible, on the basis of present information, to suggest 
a wide range of possible frequencies (and only for the most common manifestations) of 
0.03$ to 0.15$. 
4. MECHANISMS OF PRODUCTION OF ADVERSE REACTIONS 
Understanding of the mechanisms of food additive allergy or intolerance does not seem 
necessary for ascertaining the frequency of this condition, and thus providing some basis 
for regulatory decisions. However, becauee the diagnosis of such "allergy" is usually 
imprecise, information about frequency has not been easily obtained. This situation 
will only be improved when diagnostic tests become readily available which are simpler 
and more accurate than the present subjective methods. This in turn will depend on 
better understanding of the cause of the adverse reaction. Furthermore development of 
animal and/or in vitro model systems to test food components for potential allergenicity 
(and intolerance) depend on understanding of the processes involved. Therefore from both 
a regulatory and a purely scientific viewpoint, it is important to try to elucidate 
the mechanisms of food hypersensitivity and intolerance. 
The obvious first line of enquiry is to look for evidence of immunological mechanisms 
causing true allergic reactions. The basic concept in activation of the immunological 
system is that only large molecular weight substances, such as proteins, can act as 
allergic antigens and induce an immune response. It has been suggested that some food 
additives of small molecular weight can act as haptens and combine with proteins before 
acting as specific allergens. Exposure to the allergen stimulates the production from 
plasma cells in susceptible (atopic) individuals of specific antibodies which are 
distinctive in type (igE), but may also show other patterns of antibody response to 
absorbed foreign protein. These specifio IgE antibodies bind to basophils in the blood 
or mast cell results in the rapid release of histamine, serotinin, etc., which is res-
ponsible for the symptoms of immediate (reaginic) hypersensitivity (or atopy). Such 
reactions occur within minutes or several hours of ingesting food. Alternatively, a 
less well understood type of hypersensitivity can be produced: the onset of symptoms is 
typically 6—24 hours after food ingestion, but differentiation between immediate and 
delayed types of hypersensitivity cannot satisfactorily be made on the basis of the time 
interval but requires appreciation of the immunological differences involved. There has 
been much debate about the contribution of delayed hypersensitivity reactions to food 
allergy - it is a difficult condition to demonstrate - and the wide variation between 
some estimates of the overall frequency depends on whether or not delayed hypersensitivity 
type reactions are included. Resolution of this problem will be facilitated when tests 12 -
other than the standard subjective history taking and elimination/challenge procedures 
for the diagnosis of delayed hypersensitivity to food become generally available. 
Objective tests used to detect immediate hypersensitivity reactions include skin tests, 
RAST, and basophil degranulation. Unfortunately the results from these tests do not 
always agree (e.g. Pellegrin et al, 1978)· It appears that molecules such as acetyl-
salicylic acid and tartrazine do not act as haptens; and IgE antibodies do not seem to 
be involved in adverse reactions to them (Weltman et al, 1978; Bernstein et al, 1978). 
However Weliky et al (1978» 1979) have found evidenoe of correlation between eerum levels 
of an IgD tartrazine specific antibody and the clinical sensitivities of a group of 
patients. 
The extaot mechanism(s) for adverse reactions to food additives such as azo-dyes and 
benzoatos is not understood. Since cross-reaction to various analgesics and anti-
inflammatory drugs occurs, as well as to aspirin (e.g. indomethacin, phenylbutazone, 
methanamate, ibuprofen) intolerance seems probable for most patients. A chemical 
resemblance can clearly be seen between benzoates and salicylate. It may be relevant 
that tartrazine undergoes cleavage in the intestine into sulphanilic acid and a pyrazalone 
derivative. Moneret-Vautrin et al (198O) suggest that the latter substance may be 
concerned in the reaction rather than tartrazine. Some azo-dyes oan form aniline 
compounds which could explain their cross-reaction with preservatives (Walker, 1970). In 
asthmatic aspirin intolerance, an abnormal blocking of prostaglandin E2, (which is a 
broncho—dilator) haB been proposed as a possible explanation (Settipane et al, 1974). 
Such a mechanism in asthma seems logical since drugs which like aspirin induce urticaria 
and asthma are also good inhibitors of microsomal prostaglandin synthetase, but weaker 
inhibitors of this enzyme (like acetamidophen and salicylamide) often fail to produce 
symptoms (Szozeklik et al, 1975» 1977). To explain why some people react adversely to 
aspirin-like drugs while others improve, an underlying abnormaity in a metabolic pathway 
or of a particular receptor must be postulated in sensitive patients. The adverse 
reactions to tartrazine seem not to be mediated though an inhibition of prostaglandin 
eynthesis (Gerber et al, 1979). The latter believe that tartrazine sensitivity is co-
existent with that of aspirin and might have an allergio basis. Obviously, much work 
needs to be done before diagnostic tests for hypersensitivity and intolerance to food 
additives will operate from a firm factual basis. 
In the context of intolerance to aspirin and to tartrazine, there is some evidence that 
commercial impurities may perhaps be responsible for the effects produced in sensitive 
subjects. Bungard and de Weck (1974» 1975) have shown that two impurities (acetyl-
salicylic anhydride and acetylsalicylsalicylic acid) commonly present in commercial 
aspirin are capable of producing the formation of salioyloyl—specific antibodies in 
experimental animals. They suggest that similarly the antibodies detected in a number 
of patients with aspirin intolerance are due to these impurities and not to 
acetylsalicylic acid itself. However Juhlin et al (1972) found that acetylsalicylic 
anhydride did not provoke urticaria in aspirin sensitive patients. Menoret (1979)» in a 
paper submitted by the EEC Industries' Colours Group to the Commission, described skin 
sensitisation in the guinea—pig with impurity in a preparation of tartrazine; but the 
clinical relevance of this finding is doubtful. 
One final point concerning the mechanisms of production of food allergy or intolerance. 
Although the abnormal genetic bases postulated to exist in sensitive subjects may include 
for example an inherent tendency to produce IgE antibodies, and/or a defect in the metabolic 
pathway of prostaglandin synthesis, there can be little doubt that conditions in the 
gastro—intestinal tract itself must influence the fate of ingested "allergens". It may 
not require deficiency of IgA to have an impaired local defence system in the gut. If 
the normal secretions are inadequate or if the mucosa is hyperaemic or damaged, it can 
be surmised that "allergens" may more readily gain access to the gut epithelium or absorp-
tion into the body. Attention should therefore be paid to such factors as dietary habite, 
alcohol intake, medicaments, etc. when considering the production or aggravation of food 
intolerance or hypersensitivity and the possibility of mitigating its effects in 
sensitive individuals. 
5. ASSESSMENT OP THE INFORMATION AVAILABLE AND PRESENT UNCERTAINTIES ABOUT ADVERSE REACTIONS 
TO FOOD ADDITIVES 
A satisfactory basis for regulatory decision requires information on the extent of the 
clinical manifestations and the frequency of adverse reactions to food additives in the 
general population. Uncertainties exist in both areas. - 13 
There is no doubt atout the existence of allergy or intolerance to food additives, 
particularly in the form of urticaria and respiratory reactions, which can "be provoked 
by several commonly used food colouring matters,preservatives and antioxidants. 
Investigation so far suggeets in a reasonably convincing manner that the azo dye, 
tartrazine, is the most commonly implicated additive — but some allowance must be made for 
the relative usage and frequency of testing of different additives. Although the reactions 
produced by this colouring matter are usually of mild or moderate severity, occasionally 
severe asthmatic symptoms have been produced requiring intensive treatment (Pellegrin 
et al, 1978)· The extent of clinical manifestations of food additive hypersensitivity 
or intolerance to food additives in general, other than dermatological and respiratory 
disorders, is uncertain. For example, the relationship between food additive ingestion 
and behaviour probleme in children must be questioned. It is possible that the problem 
is one of very much wider implication than seemed likely initially, and one which would be 
resolved more satisfactorily by means other than extensive dietary elimination. 
A second question of clinical importance is whether food additives are capable of intially 
causing hypersensitivity or intolerance, or merely of provoking a reaction in certain 
predisposed or sensitised individuals. If additives were shown to be aetological agents 
in the general population then this would greatly influence the decision about what 
course of action to recommend. 
There is no direct information about the incidence and prevalence of hypersensitivity or 
intolerance to food additives in the general European population. The available evidence 
is derived from case reports and studies of highly selected populations. Furthermore it 
has not been established (though often supposed) that some additives such as tartrazins 
are more likely to provoke adverse reactions than others. The information required here 
would have to include data on the relative use and amounts ingested of individual 
additives, as well as the results of challenge tests. 
Much of the reason for this lack of information lies in the present incomplete 
understanding of the mechanisms involved in adverse reactions to food additives, and the 
resulting absence of suitable diagnostio tests« The mechanism underlying a reaction may 
be immunological (allergy) or non-immunological (intolerance), but the clinical mani-
festations are similar and the tests at present available do not necessarily distinguish 
between these two types of reaction. The presence of a threshold effect, found in 
challenge tests with some food additives is likely to indicate intolerance. The fact 
that there seems to be a higher incidence of intolerance to additives in adults than 
children is thought to indicate that accumulation may also occur. This might be of 
importance in children in respect of neurological manifestations of intolerance to 
food additives. 
6. RESEARCH PROPOSALS 
i) Epidemiology 
Although the ability of food additives to provoke a variety of clinical 
manifestations is widely recognised, there is a surprising dearth of fact. As haB 
already been noted such evidence as there is derives largely from isolated case 
reports and studies of highly selected populations. Accordingly, it is of prime 
importance to establish the incidence and prevalence of intolerance or hypersensitivity 
to these substances in the general European population. Several population cohorts 
should be studied on a geographical basis e.g. France, Britain, Germany, Italy. If 
an area exists in which no additives are used, then it would be helpful also to carry 
out investigations in such a population. The cohorts studied should be as 
representative of the general population as possible. Ideally, randomly selected 
volunteer individuals from general practitioners* lists should be included. Both 
prevalence (the number of individuals at a single point in time suffering from 
adverse reactions to food additives) and incidence (the number developing symptoms 
over a defined period of time) should be determined, to avoid errors due to clustering 
in time. The size of cohorts and their selection should be determined after detailed 
discussions with epidemiologists and statisticians. 
Detailed case histories of skin or respiratory symptoms and possible relationships 
to food factors should be made using standardised questionnaires. Any history of 
associated diseases (eczema, asthma, migraine, oontact allergic dermatitis, rhinitis, 
drug reactions, etc.) should be noted. In addition to case histories, use will have 14 
to be made of diagnostic tests despite their present limitations. Hopefully 
research into basic mechanisms (eee below) will result in better diagnostic tests 
being developed which clearly distinguish between reactors and non-reactors. 
ii) Basic mechanisms involved in food additive intolerance or hypersensitivity: 
a) Understanding of the basic mechanisms may be helped by looking for specific 
differences in, for example, genetio and immunological factors between members 
of the local population who show a reaction and those who do not. 'Markers' 
could include HLA type and serum levels of IgB, complement factors, immune 
complexes, rheumatoid factor, and auto-antibodies including anti—nuclear factor; 
also levels of circulating antigens. Similarly, investigation of pharmacological 
mediatros for poesible information about non—immunological mechanisms is required. 
Perhaps these and the epidemiological surveys will throw some light on the problem 
of whether food additives are primary aetiological factors or aggravating factors 
in sensitive subjects. 
b) Specific information about the mechanism(s) involved may be obtained from the 
following investigations in reactors: 
Histology and immunopathology — Biopsy with direct immunofluorescence studies for 
immunoglobins and complement, and special stains for mast cells, in addition to 
routine histological examination. 
Immunology - Isolation of haptens; isolation and purification of antigen (the 
consistent presence of a particular impurity may be relevant); immunodiffusion 
precipitin and haemagglutination tests for specific circulating Igü/lgM antibodies; 
radio-immunoaseay for IgE (reaginic) and IgD antibodies; lymphocyte transformation 
tests, and tests based upon release of macrophage inhibition factor (MIP) in 
situations where a cell-*iediated immune response is queried. 
Pharmacology - To study the reactions involved in the intermediate stages of a 
response:- pharmacological analysis of venous blood, during lung and skin 
reactions initiated by systemic challenge, for kinins and other vasoactive 
peptides, slow reacting substance of anaphylaxis (SRSA), histamine, prostaglandin, 
serotonin; incubation of patients' leucocytes with food additives, and acetyl 
salicylic acid, and measurement of the release of histamine, prostaglandins, 
SRSA, hydroxy fatty acids and lysomal enzymes; analysis of skin exudate (obtained 
during onset, development and regression of lesion evoked by systemio challenge) 
for levels of such factors. 
Pharmacodynamics of acetyl salicylic aoid and tartrazine - The influence of 
aspirin and tartrazine on pharmacological mediator release or formation in vitro 
and in vivo need to be studied. Appropriate in vitro models should include 
antigen provoked histamine release from human skin and leucocytes and rat perito-
neal mast cells, and biosynthesis of prostaglandins and related compounds (SRSA) 
from arachidonic acid by cyclo—oxygenase and lipoxygenase from seminal vesicle 
and skin. In vivo, measurement of pharmacological activity in venous blood, as 
outlined above, should be carried out after oral challenge. 
Pharmacokinetics of acetyl salicylic acid and tartrazine - The absorption, 
distribution, plasma "half life and urinary excretion of tartrazine and acetyl 
salicylic acid should be compared in control and reactive individuals. 
Biotransformation — Attempts should be made to identify the metabolites of 
additives which can provoke adverse reactions. An attempt should also be made to 
correlate pharmacokinetic findings with genetic factors (see earlier section). 
The influence of non-covalent bindings to macromolecules such as albumin on the 
reactivity of tartrazine and other additives should be studied. 
Structure-activity relationships - Characterisation of metabolites and conjugates 
and identification of in vitro models showing speoific reactivity with food 
additives or derivatives should enable detailed structure-activity relationships 
to be established. 15 -
The possible influence of any consistent impurity(ies) in an additive, on 
pharmacologicalι as well as immunological processes, should be investigated. 
iii) Development of animal models 
Although animal toxicity data on food additives are available, these studies do 
not often include tests for allergenic potential. Evaluation of local irritant 
potential can be achieved using the Draize test (1944) or a modification of it. 
The readiness with which a food additive can induce delayed cell mediated immunity 
can be evaluated using the guinea pig maximisation test (Magnusson and Kligman, 
1969)· Animal models can also be used for detecting the production of immediate 
(igE-mediated) hypersensitivity of the anaphylactic type and to reveal induction 
of complement-dependent immune complex-mediated and cytotoxic immune allergic 
reactions. 
However the actual importance of allergic mechanisms in food additive-evoked 
clinical states is uncertain. There is considerable evidence to suggest that, on 
the contrary, non-immune mechanisms may be involved. The ability of aspirin to 
exacerbate wealing in patienta with chronic urticaria is a widely recognised fact, 
but no evidence of an immune basis for this phenomenon is recognised. It seems 
probable that an interaction between aspirin and the arachidonate-prostaglandin 
cascade is involved (Sullivan and Parker, 1979 5 Marone et al, 1979). 
Thus new animal models and in vitro test systems will have to be devised. These 
models would be useful not only for studying the mechanism(s) of clinically 
indistinguishable intolerance or hypersensitivity reactions but would also form an 
essential step in the safety-in—use assessment of proposed new food additives. It 
will be necessary to have models which can predict the likelihood of a particular 
additive causing a reaction due to either allergy or intolerance. 
7. DISCUSSION 
Label? or Ban? 
Although insufficient information is available on the frequency in the general population 
of adverse reactions to food additives, or of the extent of the clinical manifestations 
which may be so provoked, to provide an ideal basis for regulatory decision making, it 
has been established that several food additives are capable of causing symptoms of 
allergy or intolerance in susceptible individuals who may constitute about 0.03 to 
0.15$ of the population. Everyone has the right to know what ingredients and additives 
are present in food, drug formulations and cosmetics. Information on the occurrence of 
additives in food and drugs is a matter of the utmost importance for individuals who are 
susceptible to adverse reactions. It seems a basic precaution therefore to give adequate 
warning by labelling. It is important that the wording is not only clearly visible, but 
also readily understandable to the lay person i.e. chemical formulae are not required, but 
a conventional name (e.g. erythrosine) or abbreviation (e.g. BHA), together with the 
appropriate Ξ number (in brackets) should be employed. Thus a general requirement exists 
for information to be provided about all additives and ingredients present in food, but 
consideration needs to be given to certain problems associated with the use of labelling 
as a means of giving information about additives in foods: for instance it is not readily 
apparent how food labelling can help the individual eating out in a restaurant. 
It cannot be emphasised too strongly that what is required is labelling to indicate all 
additives used - not just those which appear at present to be most frequently involved 
in provoking adverse reactions to food. It is likely that amongst the less frequently 
used and investigated additives are some with an equal potential to provoke adverse 
reactions due to intolerance or hypersensitivity. Furthermore, such a complete declaration 
might indirectly serve to question the need for the presence of numerous additives in 
some foods - so that stimulus might be given to apply more rigorously the principle 
of only using additives when a definite case of technological need exists. 
Is labelling enough; or should more be done? Ideally from the point of view of the 
nutritional scientist, food additives with a purely "aesthetic" effect, such as colouring 
matters; and which provoke symptoms of allergy or intolerance, should not be used and it 
would perhaps be reasonable enough to ban the use of such colours in food. However, 
in drugs, the use of different colouring agents can afford an additional element of 16 -
safety in discriminating between different drugs Taut other methods are also possible. 
In this case banning could perhaps only satisfactorily be contemplated if it were possible 
to prove that the risk was one of inducing rather than aggravating a disease state, or 
if it were possible to be certain that the benefit derived from the use of colours in 
medicines could be preserved by substituting colours which were not similarly capable of 
provoking adverse reactions. At the moment neither of these premises is valid. However, 
bearing in mind the facts that a) a dose response relationship exists for the type of 
intolerance with which colours such as tartrazins seem to be associated and b) that the 
amount of a colour used can vary widely, it would be reasonable to suggest that the amount 
of colour permitted could be restricted both in foods and on/in different drug formulations. 
Furthermore, tartrazine (or any colouring agent similarly able to provoke adverse reactions) 
should be removed from the formulation of any drug likely to be prescribed for allergio 
subjects (e.g. antihistamines, beta—stimulators, antibiotics) or customarily taken daily 
over a long period of time by large sections of the population (e.g. contraceptive pille, 
tranquilisers). Of course, removing, reducing the quantity of, or labelling colours 
would not dispose of the similar but smaller problem with preservatives and antioxidants 
(in food, drugs and cosmetics), nor the common risk of allergic symptoms arising from 
natural food ingredients. 
8. CONCLUSIONS 
a) On the basis of currently available evidence, it is considered that the presence of 
all food ingredients, and additives in food, drugs and cosmetics should be clearly 
indicated by labelling. Furthermore it is suggested in the case of food colouring 
matters that the amounts used could be considerably reduced; and that no colouring 
matter which can provoke an adverse reaction in a sensitive individual, should be 
included in the formulation of drug preparations prescribed for the treatment of 
allergic conditions, or for large sections of the population on a long term basis. 
When further information is available from the research suggested in c) below, it may 
be advisable to consider if further action is indicated. 
b) Action is required to try to prevent new additives being introduced into food, drugs or 
cosmetics with a potential for provoking reactions due to intolerance or hypersensitivity. 
Appropriate animal and/or in vitro test systems (for detecting such potential 
"allergenicity") should be adopted in future toxicity assessments. Ideally all 
existing food additives should also be tested for allergenicity, but this would be 
quite impracticable; however, those suspected of provoking adverse reactions should 
be investigated. 
c) Finally, there is an immediate and fundamental need for research to be carried out on 
the epidemiology of, and basic mechanisms concerned in adverse reactions to food 
additives. This will include development of idagnostic tests for allergy and intolerance 
to food additives. - 17 
DEFINITIONS 
ANNEX I 
(NB It is difficult to give definitions which are universally acceptable in different 
languages for many of the terms used in discussing hypersensitivity and intolerance. 
The following definitions explain the meanings intended in this paper, and are based on 
Dorland's Medical Dictionary, 25th Edition.) 
1. Basic Mechanisms 
allergen 
allergy 










a foreign substance which provokes a harmful immune 
response 
a hypersensitive etate acquired through exposure to 
a particular allergen, reexposure bringing to light 
an altered capacity to react by an immune response 
the use of quotation marks implies that in the 
particular context (of e.g. a reference from the 
literature) it is unclear whether an immunological 
or other process is involved 
an unusual exaggerated allergic reaction to a foreign 
protein or other substance 
an immunoglobulin which reacts in the (humoral) 
immune response specifically with the antigen, 
allergen or hapten which induced its synthesis in 
lymphoid tissue 
any substance which is capable of inducing the 
formation of antibodies and of reacting specifically 
with them 
an hereditary predisposition to develop some form of 
allergy (hypersensitivity) such as asthma or hay 
fever: an unusual type of antibody (reaginie, IgE 
class) is involved 
a specific immune response mediated by predominantly 
small lymphocytes of thymic origin (but also involving 
macrophages and antibody). 
a simple protein free substance which is only 
capable of causing an immune response if it becomes 
coupled to a carrier protein 
an abnormal (exaggerated) reaction to a foreign 
agent effected by the immune response or chemical 
mediators 
Type 1 - immediate hypersensitivity reaction 
Type II — injury is produced by an antibody against 
tissue antigene 
Type III — injury is produced by antigen-antibody 
complexes 
Type IV — delayed hypersensitivity reaction 
an immune response mediated predominantly by IgE 
antibodies, and characterised by lesions resulting 
from the release of histamine and other vasoactive 
substances 
normal immune reaction to foreign antigen; mani-
fested as antibody production or cell-raediat __ 
immunity /»\ W ® *, 
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mast cells and basophils 
plasma cells 
radioallergosorbent tests (RAST) 
protein with antibody activity, responsible for 
humoral aspects of immunity 
antibody predominantly in secretions 
antibody present in small amount in the blood. 
Its biological function has not yet been clearly 
defined 
antibody of importance in immediate hypersensitivity 
antibodies predominantly in blood and tissues 
an abnormal, but non-immune reaction to a foreign 
substance, which is determined by a particular 
characteristic of certain individuals (e.g. enzyme 
abnormality) 
non—immunologically determined abnormal clinical 
response to a foreign substance 
specialised white cells which mediate immune 
reactions both humoral and cell mediated 
scavenger cells 
cells which release inflammatory substances (e.g. 
histamine, heparin) in immediate hypersensitivity 
reactions 
lymphocyte derived white cells which synthesise 
immunoglobulins 
laboratory tests using radio-immunoassay to detect 
IgE antibody to specific allergens in patients with 
immediate hypersensitivity 
2. Clinical 
challenge tests for immunological 
hypersensitivity 
angio oedema (giant urticaria, 




suspected allergens can be ingested, applied 
sublingually, inhaled or given as a skin test 
(superficially, intradermally or subcutaneously) 
a condition closely related to urticaria in which 
the swellings occur in the subcutaneous tissues 
instead of in the skin: pain is common and itching 
less so 
an inflammatory condition of the skin which may be 
extensive or patchy in distribution. In its acute 
form it is characteristically a papular, blistering, 
exudative eruption which is accompanied by intense 
redness, itching, pain and swelling. In the chronic 
form, thickening, dryness, cracking, scaling, 
persistent itching and excoriation are the main 
features 
redness of the skin due to dilation of the blood 
vessels 
a symmetrical eruption of red macules, papules and 
blisters, usually with purpura. Accompanying 
ulceration of the mucous membranes is common and 
the patient may be febrile 19 -




urticaria (hiveef "nettle rash") 
an acute inflammatory reaction to syatemically 
administered drugs, often with blistering, but 
always at the same site or sites 
swelling due to the presence of abnormally large 
amounts of fluid in the intercellular tissue spaces 
of the body 
a rash due to haemorrhages into the tissues which 
are visible through the epidermis. Small (less than 
3 mm) purpuric lesions are called petechiae, and 
larger ones echymoses· Purpura occurs as a result of 
damage to walls of small blood vessels, which may be 
of an inflammatory or non-inflammatory type. When 
the purpura is due to inflammatory change in blood 
vessels, the term vasculitis is used to describe 
the eruption 
consists of oedema of, and increased secretion from 
the nasal mucosa, with itching and obstruction. 
It may be accompanied by loss of taste and smell 
transient, circumscribed swellings (weals) surrounded 
by erythema, associated with itching, and of 
generalised distribution. Swellings rarely last more 
than 24 hours, and usually last only 2-4 hours. 
Several clinical varieties are recognised. Chronic 
urticaria, when there are recurrent episodes, is by 
far the commonest variety. 20 
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